Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Sees Large Decline in Short Interest

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) saw a significant decline in short interest during the month of January. As of January 30th, there was short interest totaling 73 shares, a decline of 99.7% from the January 15th total of 23,987 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average trading volume of 11,363 shares, the short-interest ratio is presently 0.0 days. Based on an average trading volume of 11,363 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the shares of the stock are short sold.

Bitwise MARA Option Income Strategy ETF Stock Down 2.9%

Shares of IMRA traded down $0.40 during mid-day trading on Tuesday, reaching $13.39. 954 shares of the company’s stock were exchanged, compared to its average volume of 7,854. The company has a 50-day simple moving average of $16.73 and a two-hundred day simple moving average of $28.03. Bitwise MARA Option Income Strategy ETF has a 52-week low of $11.99 and a 52-week high of $60.73. The company has a market cap of $3.21 million, a price-to-earnings ratio of 267.80 and a beta of -6.67.

About Bitwise MARA Option Income Strategy ETF

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.